Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant FOLR1 (Farletuzumab Biosimilar) antibody

Reactivity: Human ELISA, Func, FACS, SPR, BLI Host: Human Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7581415
  • Target
    FOLR1 (Farletuzumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    • 1
    • 1
    • 1
    Human
    Expression System
    CHO Cells
    Clonality
    • 3
    • 1
    Monoclonal
    Conjugate
    • 4
    This FOLR1 (Farletuzumab Biosimilar) antibody is un-conjugated
    Application
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    ELISA, Functional Studies (Func), Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI)
    Purpose
    Anti-FOLR1 / FRA Reference Antibody (farletuzumab)
    Sequence
    EVQLVESGGG VVQPGRSLRL SCSASGFTFS GYGLSWVRQA PGKGLEWVAM ISSGGSYTYY ADSVKGRFAI SRDNAKNTLF LQMDSLRPED TGVYFCARHG DDPAWFAYWG QGTPVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK,DIQLTQSPSS LSASVGDRVT ITCSVSSSIS SNNLHWYQQK PGKAPKPWIY GTSNLASGVP SRFSGSGSGT DYTFTISSLQ PEDIATYYCQ QWSSYPYMYT FGQGTKVEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN NFYPREAKVQ WKVDNALQSG NSQESVTEQD SKDSTYSLSS TLTLSKADYE KHKVYACEVT HQGLSSPVTK SFNRGEC
    Characteristics
    Anti-FOLR1 Reference Antibody (farletuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.12 kDa.
    Purity
    >95 %
    Isotype
    IgG1
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Therapeutic Agents by Target and Mechanism: FOLR1 antagonist

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    1 mg/mL
    Buffer
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    Storage
    4 °C,-80 °C
    Storage Comment
    +4°C,-80°C
  • Target
    FOLR1 (Farletuzumab Biosimilar)
    Target Type
    Biosimilar
    Molecular Weight
    144.12 kDa
    UniProt
    P15328
You are here:
Support